Sakai Y - Search Results

1

Current Practice and Outcomes of Peritoneal Dialysis in the Nippon Medical School Musashi Kosugi Hospital.

Sumi Y, Sakai Y, Mugishima K, Suzuki A, Otsuka Y, Otsuka T, Tsuruoka S. Sumi Y, et al. Among authors: sakai y. J Nippon Med Sch. 2018;85(2):102-109. doi: 10.1272/jnms.2018_85-16. J Nippon Med Sch. 2018. PMID: 29731493 Free article.

2

Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab.

Sakai Y, Sakai S, Otsuka T, Ohno D, Murasawa T, Munakata K, Mizuno K. Sakai Y, et al. Among authors: sakai s. Ther Apher Dial. 2009 Jun;13(3):179-85. doi: 10.1111/j.1744-9987.2009.00657.x. Ther Apher Dial. 2009. PMID: 19527463 Clinical Trial.

3

Efficacy of aliskiren in Japanese chronic kidney disease patients with hypertension.

Sakai Y, Otsuka T, Ohno D, Murasawa T, Sato N, Mizuno K. Sakai Y, et al. Ren Fail. 2012;34(4):442-7. doi: 10.3109/0886022X.2011.649672. Epub 2012 Jan 20. Ren Fail. 2012. PMID: 22260457

4

History and current practice of blood purification therapy in nippon medical school musashi kosugi hospital: 31 years of practice.

Sakai Y, Kadomatsu Y, Sakai S, Otsuka T, Ohno D, Murasawa T, Sato N, Mizuno K. Sakai Y, et al. Among authors: sakai s. J Nippon Med Sch. 2012;79(5):357-61. doi: 10.1272/jnms.79.357. J Nippon Med Sch. 2012. PMID: 23123392 Free article.

5

The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure.

Otsuka T, Sakai Y, Ohno D, Murasawa T, Sato N, Tsuruoka S. Otsuka T, et al. Among authors: sakai y. Clin Exp Nephrol. 2013 Dec;17(6):834-8. doi: 10.1007/s10157-013-0788-6. Epub 2013 Mar 13. Clin Exp Nephrol. 2013. PMID: 23483323 Free PMC article.

6

Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease.

Sakai Y, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Otsuka T, Ohno D, Murasawa T, Tsuruoka S. Sakai Y, et al. Int J Nephrol Renovasc Dis. 2013 Oct 11;6:223-7. doi: 10.2147/IJNRD.S52905. eCollection 2013. Int J Nephrol Renovasc Dis. 2013. PMID: 24143121 Free PMC article.

7

Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease.

Sakai Y, Otsuka T, Ohno D, Murasawa T, Sato N, Tsuruoka S. Sakai Y, et al. Ren Fail. 2014 Mar;36(2):225-31. doi: 10.3109/0886022X.2013.844622. Epub 2013 Oct 24. Ren Fail. 2014. PMID: 24152124

8

Effects of alogliptin in chronic kidney disease patients with type 2 diabetes.

Sakai Y, Suzuki A, Mugishima K, Sumi Y, Otsuka Y, Otsuka T, Ohno D, Murasawa T, Tsuruoka S. Sakai Y, et al. Intern Med. 2014;53(3):195-203. doi: 10.2169/internalmedicine.53.1292. Intern Med. 2014. PMID: 24492687 Free article.

9

Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.

Sakai Y, Otsuka T, Ohno D, Murasawa T, Sakai S, Tsuruoka S. Sakai Y, et al. Among authors: sakai s. Ther Apher Dial. 2014 Apr;18(2):181-4. doi: 10.1111/1744-9987.12099. Ther Apher Dial. 2014. PMID: 24720409

10

A case of neuromyelitis optica spectrum disorder with early successful induction of double filtration plasmapheresis.

Sakai Y, Otsuka T, Tsuruoka S. Sakai Y, et al. Ther Apher Dial. 2014 Jun;18(3):317-8. doi: 10.1111/1744-9987.12216. Ther Apher Dial. 2014. PMID: 24965298 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,603 results

Search Page

Filters